Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "Cardiac Ablation Market - A Global and Regional Analysis: Focus on Application, Product, End User, and Region - Analysis and Forecast, 2025-2035" report...
-
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Ablation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024...
-
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cardiac Mapping Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global landscape...
-
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Cardiac Ablation Devices Market" report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the...
-
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share...
-
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Cardiac Ablation: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cardiac Ablation...
-
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Cardiac Ablation Catheters Market" report has been added to ResearchAndMarkets.com's offering. In 2019, an estimated 1,115,550 cardiac catheter...
-
MINNEAPOLIS, July 29, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM), a proprietary technology platform designed to improve the fidelity of...
-
BioSig Technologies, Inc. Appoints David Weild to Its Board of Directors as Audit Committee Chairman
MINNEAPOLIS, May 26, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) today announced that it has appointed David Weild to the Board of Directors, effective immediately. Mr. Weild has...
-
MINNEAPOLIS, May 20, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM) a proprietary technology platform designed to improve the clarity of...